| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Clarus Lifesciences Iii, L.P. is a 10% Owner at PRAX with holdings across 3 companies. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $1952.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 | BX Blackstone Inc. | 10% Owner | Buy | 150,000 | $16.00 | $2,400,000.00 | +4.7% | +19.9% | +1.0% | |
| May 11, 2021 | BX Blackstone Inc. | 10% Owner | Buy | 30,000 | $17.00 | $510,000.00 | +0.4% | +30.9% | +14.2% | |
| Sep 29, 2020 | BX Blackstone Inc. | 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +14.9% | - | - | |
| Jul 28, 2020 | BX Blackstone Inc. | 10% Owner | Buy | 200,000 | $17.00 | $3,400,000.00 | +7.9% | - | - |